In fact, FPR2 blockade using a specific antagonist revealed that this receptor facilitates the survival of GBM cells under basal conditions and in response to chemotherapy, suggesting that the HN/FPR2 pathway may be important in the intrinsic resistance of GBM to cytotoxic stimuli. The gene discussed is FPR2; the disease is glioblastoma.